从病房库存中移除维护吸入器对环境,成本和工作负载的影响
Ariana Javer1, Karyssa Boyle1, Valeria Stoynova2,3
1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
The International journal of pharmacy practice
|July 18, 2025
概括
从医院病房库存中删除维护吸入器 (MI) 显著降低了30%的成本,减少了37%的碳排放. 这种环境和财务改善发生在没有对员工工作量或患者护理产生负面影响的情况下.
科学领域:
- 环境健康 环境健康
- 医疗保健管理的管理
- 药物经济学 药物经济学
背景情况:
- 维护吸入器 (MI) 通常在医院病房中储存.
- 评估病房管理对环境和财务的影响对于可持续的医疗保健至关重要.
研究的目的:
- 评估医院病房库存中停止使用维护吸入器 (MI) 的环境,财务和工作负载影响.
- 确定优化药品库存管理的可行性和好处.
主要方法:
- 加拿大不列颠哥伦比亚省的一家社区医院从病房库中删除了心脏病.
- 药房分发和补货数据被用来评估废物,成本和环境影响.
- 通过调查评估了员工的工作量.
主要成果:
- 在干预后观察到MI发放的显著和持续下降.
- 节约了30%的成本,减少了37%的碳排放.
- 干预后16个月没有报告员工工作量持续或感知到的变化.
结论:
- 消除病房库MI提供了财务优势,并减少了医疗保健的碳足迹.
- 这一策略可以实施,而不会对员工的工作量或患者护理产生不利影响.
- 优化药品库存是一种可行的方法,可以提高医疗保健的可持续性.
相关概念视频
Inhaled Medications
395
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
395
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
398
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
398
Drugs Used in Lower Respiratory Disorders: Overview
595
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
595
COPD: Management Using Bronchodilators and Corticosteroids
315
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
315


